Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

How effective is continuous glucose monitoring in intensively treated type 1 diabetes mellitus?

Abstract

This Practice Point commentary discusses the findings of a multicenter clinical trial conducted by the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. In the study, 322 individuals aged ≥8 years who were already receiving intensive insulin therapy for type 1 diabetes mellitus were randomly assigned to either a group that performed continuous glucose monitoring (CGM), or to a control group that performed conventional self-monitoring with a blood-glucose meter. At week 26, the between-group difference in the change in HbA1c level from baseline varied according to the patient's age. A significantly greater reduction in HbA1c level in the CGM group compared with the control group was found in patients aged ≥25 years, but not in those aged 8–14 years or 15–24 years. In patients aged ≥25 years, CGM improved glycemic control without increasing the frequency of hypoglycemia. Motivation, willingness to change diabetes self-care behaviors, and the ability to use CGM effectively are important determinants of whether this technology will improve glycemic control.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Kovatchev B et al. (2008) Comparison of the numerical and clinical accuracy of four continuous glucose monitors. Diabetes Care 31: 1160–1164

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Buckingham B (2008) Clinical overview of continuous glucose monitoring. J Diabetes Sci Technol 2: 300–306

    Article  PubMed  PubMed Central  Google Scholar 

  3. Garg S et al. (2006) Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabetes Care 29: 44–50

    Article  CAS  PubMed  Google Scholar 

  4. Deiss D et al. (2006) Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care 29: 2730–2732

    Article  PubMed  Google Scholar 

  5. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group et al. (2008) Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 359: 1464–1476

  6. Petitti DB et al. (2007) Serum lipids and glucose control: the SEARCH for Diabetes in Youth study. Arch Pediatr Adolesc Med 161: 159–165

    Article  PubMed  Google Scholar 

  7. Nathan DM et al. (2005) Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353: 2643–2653

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Wolfsdorf, J. How effective is continuous glucose monitoring in intensively treated type 1 diabetes mellitus?. Nat Rev Endocrinol 5, 134–135 (2009). https://doi.org/10.1038/ncpendmet1071

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet1071

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing